Literature DB >> 26310815

Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia.

Muhammad Zaeem Noman1, Meriem Hasmim1, Yosra Messai1, Stéphane Terry1, Claudine Kieda2, Bassam Janji3, Salem Chouaib4.   

Abstract

The tumor microenvironment is a complex system, playing an important role in tumor development and progression. Besides cellular stromal components, extracellular matrix fibers, cytokines, and other metabolic mediators are also involved. In this review we outline the potential role of hypoxia, a major feature of most solid tumors, within the tumor microenvironment and how it contributes to immune resistance and immune suppression/tolerance and can be detrimental to antitumor effector cell functions. We also outline how hypoxic stress influences immunosuppressive pathways involving macrophages, myeloid-derived suppressor cells, T regulatory cells, and immune checkpoints and how it may confer tumor resistance. Finally, we discuss how microenvironmental hypoxia poses both obstacles and opportunities for new therapeutic immune interventions.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  autophagy and antitumor immune response; cancer stem cells; circulating tumor cells; epithelial-mesenchymal transition; hypoxia; hypoxia-inducible factor; immune suppression; lymphoid cells; myeloid cells; programmed death-ligand 1; tumor microenvironment

Mesh:

Substances:

Year:  2015        PMID: 26310815      PMCID: PMC4628936          DOI: 10.1152/ajpcell.00207.2015

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  126 in total

1.  Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells.

Authors:  Andrea Facciabene; Xiaohui Peng; Ian S Hagemann; Klara Balint; Andrea Barchetti; Li-Ping Wang; Phyllis A Gimotty; C Blake Gilks; Priti Lal; Lin Zhang; George Coukos
Journal:  Nature       Date:  2011-07-13       Impact factor: 49.962

2.  Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis.

Authors:  Intissar Akalay; Bassam Janji; Meriem Hasmim; Muhammad Zaeem Noman; Fabrice André; Patricia De Cremoux; Philippe Bertheau; Cécile Badoual; Philippe Vielh; Annette K Larsen; Michèle Sabbah; Tuan Zea Tan; Joan Herr Keira; Nicole Tsang Ying Hung; Jean Paul Thiery; Fathia Mami-Chouaib; Salem Chouaib
Journal:  Cancer Res       Date:  2013-02-22       Impact factor: 12.701

3.  A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells.

Authors:  Ivraym B Barsoum; Chelsea A Smallwood; D Robert Siemens; Charles H Graham
Journal:  Cancer Res       Date:  2013-12-13       Impact factor: 12.701

4.  Targeting hypoxia at the forefront of anticancer immune responses.

Authors:  Muhammad Zaeem Noman; Salem Chouaib
Journal:  Oncoimmunology       Date:  2015-01-07       Impact factor: 8.110

5.  Differential regulation of two alternatively spliced isoforms of hypoxia-inducible factor-1 alpha in activated T lymphocytes.

Authors:  D Lukashev; C Caldwell; A Ohta; P Chen; M Sitkovsky
Journal:  J Biol Chem       Date:  2001-10-15       Impact factor: 5.157

6.  Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa.

Authors:  Eric T Clambey; Eóin N McNamee; Joseph A Westrich; Louise E Glover; Eric L Campbell; Paul Jedlicka; Edwin F de Zoeten; John C Cambier; Kurt R Stenmark; Sean P Colgan; Holger K Eltzschig
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

7.  The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients.

Authors:  Takuya Osada; Gabriel Chong; Robert Tansik; Timothy Hong; Neil Spector; Rakesh Kumar; Herbert I Hurwitz; Inderjit Dev; Andrew B Nixon; H Kim Lyerly; Timothy Clay; Michael A Morse
Journal:  Cancer Immunol Immunother       Date:  2008-01-10       Impact factor: 6.968

8.  Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype.

Authors:  K Ameri; R Luong; H Zhang; A A Powell; K D Montgomery; I Espinosa; D M Bouley; A L Harris; S S Jeffrey
Journal:  Br J Cancer       Date:  2010-01-05       Impact factor: 7.640

9.  PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells.

Authors:  David K Finlay; Ella Rosenzweig; Linda V Sinclair; Carmen Feijoo-Carnero; Jens L Hukelmann; Julia Rolf; Andrey A Panteleyev; Klaus Okkenhaug; Doreen A Cantrell
Journal:  J Exp Med       Date:  2012-11-26       Impact factor: 14.307

10.  In vivo T cell activation in lymphoid tissues is inhibited in the oxygen-poor microenvironment.

Authors:  Akio Ohta; Rohan Diwanji; Radhika Kini; Meenakshi Subramanian; Akiko Ohta; Michail Sitkovsky
Journal:  Front Immunol       Date:  2011-07-05       Impact factor: 7.561

View more
  131 in total

Review 1.  Role of hyperoxic treatment in cancer.

Authors:  Sei W Kim; In K Kim; Sang H Lee
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-23

Review 2.  Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges.

Authors:  John D Martin; Giorgio Seano; Rakesh K Jain
Journal:  Annu Rev Physiol       Date:  2019-02-10       Impact factor: 19.318

3.  In vitro Detection of Hypoxia using a Ratiometric Quantum Dot-based Oxygen Sensor.

Authors:  Armen Shamirian; Hamid Samareh Afsari; Asra Hassan; Lawrence W Miller; Preston T Snee
Journal:  ACS Sens       Date:  2016-09-20       Impact factor: 7.711

4.  HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells.

Authors:  Huimin Zhang; Haiquan Lu; Lisha Xiang; John W Bullen; Chuanzhao Zhang; Debangshu Samanta; Daniele M Gilkes; Jianjun He; Gregg L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-28       Impact factor: 11.205

5.  A genetically encoded fluorescent probe for imaging of oxygenation gradients in living Drosophila.

Authors:  Peter V Lidsky; Konstantin A Lukyanov; Tvisha Misra; Björn Handke; Alexander S Mishin; Christian F Lehner
Journal:  Development       Date:  2018-02-14       Impact factor: 6.868

Review 6.  Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges.

Authors:  John D Martin; Horacio Cabral; Triantafyllos Stylianopoulos; Rakesh K Jain
Journal:  Nat Rev Clin Oncol       Date:  2020-02-07       Impact factor: 66.675

Review 7.  Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity.

Authors:  John D Martin; Dai Fukumura; Dan G Duda; Yves Boucher; Rakesh K Jain
Journal:  Cold Spring Harb Perspect Med       Date:  2016-12-01       Impact factor: 6.915

8.  Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia.

Authors:  Nicole E Scharping; Ashley V Menk; Ryan D Whetstone; Xue Zeng; Greg M Delgoffe
Journal:  Cancer Immunol Res       Date:  2016-12-09       Impact factor: 11.151

Review 9.  Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.

Authors:  S Chouaib; M Z Noman; K Kosmatopoulos; M A Curran
Journal:  Oncogene       Date:  2016-06-27       Impact factor: 9.867

10.  Evaluation of Nonpeptidic Ligand Conjugates for SPECT Imaging of Hypoxic and Carbonic Anhydrase IX-Expressing Cancers.

Authors:  Peng-Cheng Lv; Karson S Putt; Philip S Low
Journal:  Bioconjug Chem       Date:  2016-07-07       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.